Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

The deal complements Jabil’s specialty in injectable drug delivery systems, like those used for popular GLP-1 diabetes drugs ...

The drug manufacturer will operate as a subsidiary of Jabil, with Fowler retaining his position as CEO. The move to acquire Pharmaceutics complements Jabil’s expertise in manufacturing ...

In a report released on January 24, Samik Chatterjee from J.P. Morgan maintained a Buy rating on Jabil (JBL – Research Report), with a price ...

The $50,000 Lightning Foundation grant will be donated to Community Action Stops Abuse, Inc.

A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today announced they have exited their equity stake in Pharmaceutics ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Jabil CEO Kenny Wilson, still in his first year at the helm of the $14.4 billion technology manufacturing company, has been benched due to an investigation into his conduct, the company said in a ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

On integration into Jabil, Pii will benefit from an expanded global infrastructure, automation and supply chain efficiencies. Pii CEO and president John Fowler stated: “This acquisition marks an ...